Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Apr 6, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • English or Spanish speaking
- • ≤18 weeks' gestation
- • Established prenatal care at EleVATE site
- • High-risk for postpartum depression by ≥1 risk factor (personal/family history, baseline EPDS≥10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss)
- • Ability to attend group prenatal visits at specified days/times
- • Willingness to be randomized
- • Ability to give informed consent
- • Any patient that has received prenatal care in a group setting previously
- Exclusion Criteria:
- • Multiple gestation
- • Major fetal anomaly
- • Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting
- • Serious medical co-morbidity necessitating more care than can be safely provided in group setting
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Saint Louis, Missouri, United States
Saint Louis, Missouri, United States
Saint Louis, Missouri, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials